Paul Hastings Advised Global Coordinators and Bookrunners in Connection with GenSight Biologics’ PIPE Financing

Paul Hastings LLP advised Chardan Capital Markets and Invest Securities as joint global coordinators and bookrunners in connection with GenSight Biologics’ private placement (PIPE). GenSight Biologics (Euronext: SIGHT) is a French biopharma company focused on developing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders.

Partner Max Kirchner led the cross-border Paul Hastings team, which also included Co-head of Equity Capital Markets and Co-chair of the Corporate Life Sciences Group Seo Salimi and partner Charles Cardon.

About Paul Hastings

With widely recognized elite teams in finance, mergers & acquisitions, private equity, restructuring and special situations, litigation, employment, and real estate, Paul Hastings is a premier law firm providing intellectual capital and superior execution globally to the world’s leading investment banks, asset managers, and corporations.